Potential solution to melanoma's resistance to vemurafenib
Tuesday, February 28, 2012 - 20:30
in Health & Medicine
Researchers have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.